Afrigen Biologics and Vaccines

Afrigen Biologics and Vaccines is a South African biotechnology company focused on the development, formulation, and manufacture of vaccines and biologicals for underserved markets. The company serves as the global hub for the World Health Organization (WHO) mRNA vaccine technology transfer initiative, designed to build manufacturing capacity in low- and middle-income countries. Afrigen specializes in mRNA platform technologies, lipid nanoparticle delivery systems, and novel adjuvant formulations. Their current pipeline includes vaccine candidates for COVID-19, tuberculosis, and malaria. By providing contract development and manufacturing services, Afrigen aims to enhance regional health security across the African continent.